Source: Citybizlist

Arch Therapeutics: Arch Therapeutics Completes Financing as Bridge to Uplisting

FRAMINGHAM, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a marketer and... Read MoreThe post Arch Therapeutics Completes Financing as Bridge to Uplisting appeared first on citybiz.

Read full article »

Arch Therapeutics's Competitors | Arch Therapeutics's News | Arch Therapeutics's Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

1-25

Chairman & CEO

Terrence W. Norchi

CEO Approval Rating

90/100

Arch Therapeutics is a Massachusetts-based medical device company that designs and manufactures wound care and surgical devices for the healthcare industry.